PRKACA CLIA Kit
Kurzübersicht für PRKACA CLIA Kit (ABIN6220665)
Target
Alle PRKACA CLIA Kits anzeigenReaktivität
Nachweismethode
Methodentyp
Detektionsbereich
Applikation
Proben
-
-
Untere Nachweisgrenze
- 0.156 ng/mL
-
Verwendungszweck
- Human Protein Kinase, cAMP Dependent Catalytic Alpha (PRKACa) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates, cell lysates and other biological fluids.
-
Analytische Methode
- Quantitative
-
Sensitivität
- < 0.061 ng/mL
-
-
-
-
Applikationshinweise
-
Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.
Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.
Standard Form: Lyophilized
-
Plattentyp
- Pre-coated
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Upon receipt, store the kit according to the storage instruction in the kit's manual.
-
Haltbarkeit
- 6 months
-
-
- PRKACA (Protein Kinase A, alpha (PRKACA))
-
Andere Bezeichnung
- PRKACA
-
Pathways
- NF-kappaB Signalweg, Hedgehog Signalweg, EGFR Signaling Pathway, Neurotrophin Signalübertragung, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion
Target Alle PRKACA CLIA Kits anzeigen
-